Publications
- Higher line treatment of metastatic renal cell carcinoma2021 | First Faculty of Medicine
- ARTA treatment of metastatic castration-resistant prostate cancer - case report2021 | First Faculty of Medicine
- Cabozantinib in the treatment of metastatic renal cell carcinoma - final data analysis from four oncology centers in the Czech Republic2021 | First Faculty of Medicine
- Strategies sequential treatment of metastatic castration-resistant prostate cancer2020 | First Faculty of Medicine
- Enzalutamide in treatment of the metastatic castrate resistant prostate cancer2019 | First Faculty of Medicine
- Enzulutamide in treatment in patients with metastatic castration-resistant prostate cancer after previous chemotherapy2017 | First Faculty of Medicine
- Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-resistant Prostate Cancer after Chemotherapy2016 | First Faculty of Medicine
- Klinická onkologie2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Favorable prognostic significance of membranous β-catenin expression and negative prognostic significance of cytoplasmic β-catenin expression in pancreatic cancer2023 | First Faculty of Medicine, Third Faculty of Medicine
- Strategies for the treatment of urothelial carcinoma of the bladder2023 | First Faculty of Medicine
Loading network view...